Japanese Market Entry: The Current State of Software as a Medical Device
Software as a medical device (SaMD) is a new wave of software-driven technology with the potential to deliver more personalized approaches to disease detection, management, and treatment. In Japan, which is already an important market for medical device and digital therapeutics—SaMD represents an exciting but challenging new era.
Dive into our recent roundtable report to discover:
- Japan is a large, important market for medical devices
- SaMD and AI are transforming healthcare
- The future for SaMD and for digital therapeutics is tremendously exciting
- In attempting to globalize their innovations and enter the Japanese market, companies face multiple challenges
- CMIC can help global companies enter the Japanese market
This roundtable report is based off a panel discussion with several industry experts and moderated by Citeline:
- Nathan Buchbinder, Chief Strategy Officer, Proscia
- Dr. Satoshi Iwasaki, Head, IT Digital Department, Pharma Business Strategy Division, Mitsubishi Tanabe Pharma Corporation
- Loren Larsen, CEO, Videra Health
- Romain Marmot, President, Aptar Pharma
- Shuta Mitomo, Principal, Consulting & Navigation Unit, CMIC Holdings
- Masahiro Nohara, Senior Consultant, Medical Device Consulting Department, CMIC
- Ian Haydock, APAC Editor in Chief, Citeline (Moderator)
Download your complimentary copy to learn more about this exciting topic!
